Delivery Order SPE2DB22D9205-SPE2DB25FZG07
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $1,691.16 on June 18, 2025, for VisionBlue 0.06% syringes in 0.5 mL quantities. The contract, which carries no set-aside designation, is a firm fixed-price delivery order with an ultimate completion date of July 11, 2025. The place of performance is located in Park Ridge, Illinois, and the funding agency is the Defense Logistics Agency (DLA),...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $3,382.32 to DMS Pharmaceutical Group Inc. on April 24, 2025, for the supply of VisionBlue 0.06% syringes in 0.5mL quantities. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform delivery at its Park Ridge facility with an ultimate completion date of May 15, 2025. This delivery order was issued without a set-aside designation,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,382.32 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, on August 19, 2025. This firm fixed-price delivery order, with an ultimate completion date of September 10, 2025, covers the supply of VisionBlue 0.06% syringes in 0.5ml units. The award was made without a set-aside designation, allowing DMS Pharmaceutical Group to compete on its merits within the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,227.90 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of VisionBlue 0.06% syringes in 0.5ML units. This firm fixed-price delivery order, issued on August 25, 2025, with an ultimate completion date of September 16, 2025, carries no set-aside designation. DMS Pharmaceutical Group is performing the work at its Park Ridge facility and will...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $5,073.48 contract is for the delivery of VISIONBLUE 0.06% SYRINGE 0.5ML. The order has a period of performance through June 30, 2025. DMS Pharmaceutical Group holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a $3,268.08 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler in Park Ridge, Illinois. The contract is for the delivery of 0.5ML VISIONBLUE 0.06% syringes and has a completion date of May 13, 2024. This delivery order is issued under DMS Pharmaceutical Group's $499,999,999 indefinite delivery contract (IDC) with the DLA's Medical Supply Chain...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at two thousand three hundred thirty four dollars and seventy eight cents ($2,334.78) by the Defense Logistics Agency. This order was issued against DMS Pharmaceutical Group's indefinite delivery contract to supply pharmaceutical and medical products to support military treatment facilities worldwide. Under this particular order, DMS Pharmaceutical Group will deliver VisionBlue 0.06% syringes in 0.5mL...
- The Defense Logistics Agency (DLA) awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for VisionBlue 0.06% syringes in 0.5mL quantities. This firm fixed-price delivery order, valued at $8,455.80, is scheduled for completion by September 23, 2025, and was awarded on September 2, 2025. The award carries no set-aside designation, allowing the vendor to compete on a competitive basis. DMS Pharmaceutical...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at three thousand eight hundred ninety-one dollars and thirty cents ($3,891.30) by the Defense Logistics Agency to provide 0.5ml syringes of the 0.06% concentration of the pharmaceutical product VisionBlue. The delivery order was awarded on December 5, 2023 and is to be completed by December 27, 2023. DMS Pharmaceutical Group will deliver the VisionBlue syringes to the place of performance in Park Ridge,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,382.32 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, on August 28, 2025. This firm fixed-price delivery order is for VisionBlue 0.06% Syringe 0.5ML, an ophthalmic pharmaceutical product, with a completion date of September 19, 2025. The award was made without a set-aside designation, and performance will occur at the contractor's facility in Park...
- SPE2DB22D9205Indefinite Delivery Contract
- SPE2DB22D9205-SPE2DB25FZG07Delivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $2,536.74 by the Defense Logistics Agency (DLA) on April 24, 2025, for the supply of VisionBlue 0.06% syringes in 0.5ml quantities. The contract operates under a firm fixed-price structure with an ultimate completion date of May 15, 2025, and carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the DLA valued at $499,999,999 and valid through November 2026, which enables the agency to procure a comprehensive range of pharmaceutical products and medical supplies to support Department of Defense healthcare facilities worldwide. As a critical supplier within the federal pharmaceutical supply chain, DMS Pharmaceutical Group leverages its extensive portfolio to provide branded and generic prescription drugs, biologics, and medical consumables to military health facilities. The DLA SPE2DB program vehicle under which this delivery order is issued demonstrates the company's established relationship with the agency and its capacity to efficiently distribute specialized pharmaceutical products to support military medical operations globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 4/24/25 |